In the same vein, wound healing assays evidence that in ERα-positive breast cancer cells, adiponectin, and IGF-I enhance cell motility and the co-treatment results in an additive effect, addressing how adiponectin may synergize with IGF-IR signaling. This evidence concerns the gene ESR1 and breast carcinoma.